Real-time monitoring of binding events on a thermostabilized human A2A receptor embedded in a lipid bilayer by surface plasmon resonance.
Membrane proteins (MPs) are prevalent drug discovery targets involved in many cell processes. Despite their high potential as drug targets, the study of MPs has been hindered by limitations in expression, purification and stabilization in order to acquire thermodynamic and kinetic parameters of small molecules binding. These bottlenecks are grounded on the mandatory use of detergents to isolate and extract MPs from the cell plasma membrane and the coexistence of multiple conformations, which reflects biochemical versatility and intrinsic instability of MPs. In this work ,we set out to define a new strategy to enable surface plasmon resonance (SPR) measurements on a thermostabilized and truncated version of the human adenosine (A2A) G-protein-coupled receptor (GPCR) inserted in a lipid bilayer nanodisc in a label- and detergent-free manner by using a combination of affinity tags and GFP-based fluorescence techniques. We were able to detect and characterize small molecules binding kinetics on a GPCR fully embedded in a lipid environment. By providing a comparison between different binding assays in membranes, nanodiscs and detergent micelles, we show that nanodiscs can be used for small molecule binding studies by SPR to enhance the MP stability and to trigger a more native-like behaviour when compared to kinetics on A2A receptors isolated in detergent. This work provides thus a new methodology in drug discovery to characterize the binding kinetics of small molecule ligands for MPs targets in a lipid environment.
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland. Electronic address: nicolas.bocquet@roche.com.
Nicolas
N
Bocquet
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Josiane
J
Kohler
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Melanie N
MN
Hug
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Eric A
EA
Kusznir
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Arne C
AC
Rufer
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Discovery Technologies, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Roger J
RJ
Dawson
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Discovery Technologies, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Michael
M
Hennig
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Armin
A
Ruf
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Walter
W
Huber
F. Hoffmann-La Roche, Pharma Research and Early Development (pRED), Molecular Design and Chemical Biology, Roche Innovation Center Basel, Grenzacherstrasse 124, Basel CH4070, Switzerland.
Sylwia
S
Huber
D058917:Adenosine A2 Receptor Antagonists / Q000737:chemistry / Q000378:metabolism*; D003902:Detergents / Q000737:chemistry; D006801:Humans; D007700:Kinetics; D008024:Ligands; D008051:Lipid Bilayers; D008563:Membrane Lipids / Q000737:chemistry / Q000378:metabolism*; D008823:Micelles; D008958:Models, Molecular; D049329:Nanostructures; D036103:Nanotechnology; D011485:Protein Binding; D055550:Protein Stability; D043705:Receptor, Adenosine A2A / Q000737:chemistry / Q000378:metabolism*; D013050:Spectrometry, Fluorescence; D020349:Surface Plasmon Resonance; D013696:Temperature
D058917:Adenosine A2 Receptor Antagonists; D003902:Detergents; D008024:Ligands; D008051:Lipid Bilayers; D008563:Membrane Lipids; D008823:Micelles; D043705:Receptor, Adenosine A2A
GPCRs; Kinetics; Nanodiscs; Scintillation proximity assay; Surface plasmon resonance